UNSPSC 51333903: Quinagolide hydrochloride

This classification denotes an antipsychotic agent with the molecular formula C20H33N3O3S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 33474X943Y, chemically known as sulfamide, n,n-diethyl-n-(1,2,3,4,4a,5,10,10a-octahydro-6-hydroxy-1-propylbenzo(g)quinolin-3-yl)-, monohydrochloride, (3-alpha,4a-alpha,10a-beta)- but more generally known as quinagolide hydrochloride, which bears US NIH Compound Identifier 3086400.

UNSPSC 51333903 Quinagolide hydrochloride is a Commodity code that shows minimal relevant recent state and local procurement activity. The sole recent opportunity posted under this code—Seminole County, Florida's IFB60459723LAS—seeks Naloxone and Safe Drug Deactivation Systems, neither of which corresponds to quinagolide hydrochloride, a dopamine agonist pharmaceutical used in endocrinology and specialty medicine. The mismatch between the code's nominal scope and the actual solicitation suggests either a tagging error in the county's procurement system or that quinagolide hydrochloride does not see regular state or local purchasing activity.

Seminole County posted the Naloxone and drug-deactivation-systems IFB on June 30, 2026, with a response deadline of July 26, 2023—a date inconsistency in the source—and seeks annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems delivered quarterly to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term with an optional one-year renewal and requires vendors to comply with E-Verify, drug-free workplace certification, and multiple insurance coverages. Without additional opportunities demonstrating regular state or local demand for quinagolide hydrochloride itself, this code presents minimal pursuit opportunity at this time.